MR in Drug Research Study Group

Program for Toronto 2008 Study Group Meeting


Monday, 5 May 2008, 18:30, Room 716 A/B

18:30 Business meeting, Announcement of new officers for 2008
18:45 Diffusion MRI as a tumor response biomarker: Consensus update and future directions
  Anwar Padhani, M.D., Ph.D., Mt Vernon Hospital, Northwood, UK
19:10 Newer approaches to imaging biomarkers in RA clinical trials: Advantages and pitfalls
  Derek Hill, Ph.D., University College London and IXICO, London, UK
19:40 DCE-MRI evaluation of atherosclerotic plaque: Status and potential role in assessing the effect of drug interventions
  Chun Yuan, Ph.D., University of Washington, Seattle, WA, USA
20:10 Update on the Alzheimer’s Disease Neuroimaging Initiative
  Cliff Jack, Ph.D., Mayo Clinic, Rochester, MN, USA
  Closing Remarks